Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Yezan Munther Haddadin currently holds 37,167 shares of Outlook Therapeutics, Inc. (OTLK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yezan Munther Haddadin has been a net buyer of OTLK stock. They have purchased $119.4K and sold $0 worth of shares.
Yezan Munther Haddadin's most recent insider trade was on May 26, 2026, when they purchased 34,000 shares at $0.44 per share.
Yezan Munther Haddadin serves as Executive at Outlook Therapeutics, Inc. (OTLK). They have executed 11 insider transactions totaling $119.4K over their tenure at the company.
Yezan Munther Haddadin holds the position of Executive at Outlook Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Yezan Munther Haddadin has shown a buying trading pattern, with $119.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Yezan Munther Haddadin was on Oct 6, 2022, when they purchased $38.4K worth of OTLK shares. This transaction involved 29,743 shares at $1.29 per share.
Yezan Munther Haddadin currently owns 37,167 shares of Outlook Therapeutics, Inc. (OTLK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Yezan Munther Haddadin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Yezan Munther Haddadin has 11 Form 4 filings on record as an insider at Outlook Therapeutics, Inc..
Set alerts for Yezan Munther Haddadin and 40,000+ other insiders.